Sleep-Wake Disorder Market Size to Reach $38.5 Billion by 2035

Sleep-wake disorder market is projected to grow from $21.4 billion in 2025 and is projected to reach $38.5 billion by 2035, growing at a CAGR of 6.1% during the forecast period 2026-2035. The global sleep-wake disorder market is evolving steadily due to the growing recognition of sleep health as an important component of overall physical and mental well-being. Increasing cases of stress-related conditions, irregular work schedules, lifestyle changes, and chronic illnesses have contributed to greater demand for sleep disorder diagnosis and treatment services. Healthcare providers are expanding the use of home-based sleep assessment tools and digital monitoring systems to improve patient accessibility and long-term condition management. In addition, ongoing advancements in wearable technologies and connected healthcare platforms are supporting the transition toward remote and continuous sleep monitoring. Greater public awareness regarding untreated sleep disorders and their impact on daily functioning is also influencing healthcare-seeking behavior across multiple age groups.

Browse the full report description of “Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/sleep-wake-disorder-market

The market is also witnessing increased integration of technology-driven therapeutic approaches, including AI-supported diagnostics, cloud-connected respiratory devices, and personalized sleep management solutions. Pharmaceutical and medical device companies are investing in research focused on neurological sleep disorders, obstructive sleep apnea, and circadian rhythm-related conditions. Collaboration between healthcare institutions and technology developers is contributing to improvements in diagnostic efficiency and patient compliance. Another notable trend is the growing adoption of telemedicine services for sleep consultations and follow-up care, particularly in regions with limited access to specialized sleep centers. Regulatory support for digital health integration and expanding clinical research activities is further shaping the development of the global sleep-wake disorder market.

Competitive Landscape of the Sleep-Wake Disorder Market

The key players in the sleep-wake disorder market are ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel Healthcare Corp. Ltd., Jazz Pharmaceuticals plc, and Takeda Pharmaceutical Company Ltd., among others. Market participants are focusing on expanding their sleep disorder portfolios through advancements in respiratory care systems, neurostimulation therapies, digital sleep monitoring technologies, and pharmaceutical research. Companies are increasingly investing in home-based diagnostics, AI-supported patient management platforms, and personalized treatment approaches to improve long-term therapy adherence. Strategic collaborations, regulatory approvals, and product innovation remain important competitive factors shaping the development of the global sleep-wake disorder industry.

• In March 2026, Eli Lilly and Company announced plans to acquire Centessa Pharmaceuticals to strengthen its neuroscience and sleep medicine portfolio. The acquisition focuses on orexin receptor agonist therapies targeting excessive daytime sleepiness, narcolepsy, and impaired wakefulness disorders. The deal demonstrates growing pharmaceutical interest in next-generation sleep-wake disorder therapeutics and orexin-based treatment platforms.

• In February 2026, Vivos Therapeutics partnered with SoundHealth to expand access to FDA-cleared sleep and airway health technologies, including the Sonu Band and Spatial Sleep platform. The collaboration combines Vivos’ provider network with AI-enabled sleep technologies to support broader adoption of non-invasive sleep wellness solutions. The partnership highlights the rising role of wearable technologies and digital therapeutics in sleep disorder management.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Disorder Type
  • By Treatment Type
  • By Diagnosis & Management Approach
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel Healthcare Corp. Ltd., Jazz Pharmaceuticals plc, and Takeda Pharmaceutical Company Ltd.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Sleep-Wake Disorder Market Report Segment

By Disorder Type

• Insomnia
• Hypersomnia
• Sleep Apnea
• Circadian Rhythm Sleep-Wake Disorders
• Parasomnias
• Dyssomnias
• Others

By Treatment Type

• Pharmacological Therapy
• Behavioral Therapy
• Light Therapy
• Device-Based Therapy
• Others

By Diagnosis & Management Approach

• Polysomnography & Sleep Studies
• Actigraphy-Based Monitoring
• Clinical Evaluation & Screening Tools
• Remote / Digital Sleep Monitoring Solutions

By Application

• Hospitals
• Home Care Settings
• Others

Global Sleep-Wake Disorder Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/sleep-wake-disorder-market